Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
13.89
+0.35 (2.58%)
At close: Mar 9, 2026, 4:00 PM EDT
13.89
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Enanta Pharmaceuticals Market Cap
Enanta Pharmaceuticals has a market cap or net worth of $403.08 million as of March 9, 2026. Its market cap has increased by 125.44% in one year.
Market Cap
403.08M
Enterprise Value
353.78M
1-Year Change
125.44%
Ranking
Category
Stock Price
$13.89
Market Cap Chart
Since March 21, 2013, Enanta Pharmaceuticals's market cap has increased from $289.30M to $403.08M, an increase of 39.33%. That is a compound annual growth rate of 2.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 392.90M | -13.69% |
| Dec 31, 2025 | 455.20M | 273.42% |
| Dec 31, 2024 | 121.90M | -38.50% |
| Dec 29, 2023 | 198.20M | -79.51% |
| Dec 30, 2022 | 967.50M | -36.34% |
| Dec 31, 2021 | 1.52B | 79.81% |
| Dec 31, 2020 | 845.30M | -30.63% |
| Dec 31, 2019 | 1.22B | -11.43% |
| Dec 31, 2018 | 1.38B | 22.59% |
| Dec 29, 2017 | 1.12B | 75.96% |
| Dec 30, 2016 | 637.80M | 2.77% |
| Dec 31, 2015 | 620.60M | -34.40% |
| Dec 31, 2014 | 946.00M | 93.06% |
| Dec 31, 2013 | 490.00M | 69.37% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Niagen Bioscience | 406.05M |
| NovaBridge Biosciences | 403.52M |
| Autolus Therapeutics | 401.88M |
| Crescent Biopharma | 400.89M |
| PureTech Health | 400.20M |
| PepGen | 390.83M |
| Benitec Biopharma | 388.45M |
| Armata Pharmaceuticals | 385.91M |